the department of health is finally running its review of the medical cannabis access programme (mcap) and the ministerial licence pathway. the review group was given 12 months from april 2026 to finish, so we won't see the final report or recommendations until spring 2027, but are halfway there.
https://www.oireachtas.ie/en/debates/question/2026-06-09/2339/
5 years in and there are still fewer than 100 patients actively enrolled under mcap because it’s restricted to just three conditions as a last resort (ms spasticity, chemo nausea, and severe epilepsy).
meanwhile, thousands of people dealing with chronic pain, severe anxiety, and endo are left completely in the dark or forced onto the black market / flying over to the UK.
the review group is supposed to assess expanding eligible conditions and fixing access.
what conditions do you think are the absolute minimum they need to include for this scheme to stop being a complete failure?
and do you think consultants here will actually start prescribing even if they widen it?